Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study

Recruiting now

Conditions studied: Vascular Malformations

In brief

Venous malformations (MVs) are congenital abnormalities of the central or periphery caused by developmental errors at different stages of embryogenesis. Histologically they are characterized by large, venous-like vascular spaces. Scleroembolization constitutes the most widespread method in the treatment of venous malformations allowing good results with low invasiveness. Currently, Bleomycin (and its derivatives) is among the most widely used sclerosing agents for slow-flowing vascular malformations (venous and lymphatic malformations) because of the low rate of local serious adverse events such as swelling, necrosis, and nerve injury compared with others.

Key facts

Study ID
NCT06189092
Run by
Istituto Ortopedico Rizzoli
People needed
65
Starts
2023-10-28
Expected to finish
2027-11-28
Last updated by the study team
2026-05-22

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.